The small GTPases of the Rho family are key intermediates in cellular signalling triggered by activated cell adhesion receptors. In this study, we took advantage of the siRNA technology to define the role of the best characterised members of the RhoGTPase family, RhoA, Rac1 and Cdc42 in the control of MMP-1, MMP-2 and type I collagen expression in normal human skin fibroblasts (HSF). A specific and long lasting repression, up to 7 day post-transfection, of the 
INTRODUCTION
Interactions between cells and the ECM components are primarily mediated through receptors of the integrins family (Hynes, 1992) . Engagement of integrin triggers the assembly of focal adhesions, induces the reorganisation of the cytoskeleton and the activation of various signalling cascades that culminate in the control of cell proliferation, survival, differentiation and gene expression (Danen et al., 1998) . This includes the expression of genes coding for ECM components and for matrix metalloproteinases (MMPs), a family of zinc-dependent proteases that collectively degrade most components of the ECM and play a major role in physiological and pathological processes involving ECM remodelling. MMP-1, the founding member of this family of enzymes, is barely expressed in normal fibroblasts spread on a rigid support and is dramatically up-regulated by inhibition of the integrins functionality (Kheradmand et al., 1998) or by interfering with integrin-mediated cytoskeleton reorganisation either with cytochalasin D (Lambert et al., 1998; Unemori and Werb, 1986) or by culturing fibroblasts in freely retracting collagen gels (Mauch et al., 1989; Lambert et al., 1992) . Other MMPs like MMP-3, MMP-13 and the membrane bound MMP-14 (MT1-MMP), a MMP-2 activator, are similarly up-regulated, while type I and type III collagen expression is inversely controlled (Haas et al., 1998; Lambert et al., 2001a; Lambert et al., 2001b; Mauch et al., 1988) .
The small GTPases of the Rho family are at the cross-road of signalling pathways initiated by receptors to diffusible biological mediators as well as by clustered integrins. These are key signaling molecules regulating the architecture of the cytoskeleton (Hall, 1998) and the assembly of proteins into focal adhesions (Hotchin and Hall, 1995) . Some of them have been implicated in the control of MMPs expression and activation. It was reported that Rac1 activity was required for the induction of MMP-1 mediated by inactivation of the α 5 β 1 integrin (Kheradmand et al., 1998) as well as for the type I collagen-dependent MMP-2 4 MMP-1 regulation by Cdc42 activation (Zhuge and Xu, 2001) . It was also observed that constitutive activation of RhoA was sufficient to trigger MMP-1 expression in fibroblasts (Werner et al., 2001; Werner and Werb, 2002) .
The function of the RhoGTPases is difficult to assess in cells that are refractory to transfection. Moreover, bacterial toxins but also mutated Rho-proteins are not fully specific for one RhoGTPase (Lerm et al., 2000; Ridley, 2001) . In this report, we used the siRNA technology (Elbashir et al., 2001) to analyze the role of the best characterised members of the RhoGTPase family, RhoA, Rac1 and Cdc42 in the control of MMP-1, MMP-2 and type I collagen expression in normal human skin fibroblasts (HSF) cultured on a rigid substrate. The silencing of Cdc42, but not RhoA nor Rac1, in HSF induces a significant overexpression of MMP-1 at both the mRNA and the protein level while the expression of MMP-2 and type I collagen is not affected. Multiple knockdown experiments and the use of chemical inhibitors demonstrate that the up-regulation of MMP-1 is dependent on the Rac1 and ERK1,2 pathways, while the RhoA-ROCK pathway was not involved and the p38 MAP kinase pathway displays an inhibitory role.
MATERIALS AND METHODS

Reagents and cells
Y-27632 was kindly supplied by A. Yoshimura (Welfide Co, Japan). PP2 and U0126 were from Calbiochem, Herbimycin A and LY294 from Sigma and SB203580 from Alexis corporation. Antibodies were purchased from the following manufacturers: mouse anti-RhoA (#sc-418), mouse anti-Stat1α (#sc-417), rabbit anti-myosin regulatory light chain (#sc-15370) and goat anti-phospho-myosin regulatory light chain (#sc-12896) from Santa Cruz Biotechnology; mouse anti-Rac1 (23A8) from Upstate Biotechnology; mouse anti-Cdc42 from BD Biosciences; rabbit anti-ERK-1,2 (M-5670) and mouse monoclonal anti-phospho-5 MMP-1 regulation by Cdc42 ERK1,2 (M-8159) from Sigma, mouse monoclonal anti-human p38 (AHO0782) and rabbit polyclonal anti-phospho-p38 (44-684Z) were from BioSource International, mouse antihuman MMP-1 (Mab3307) from Chemicon, mouse blocking anti-human MCP-1 (Mab279) and anti-human IL-8 (Mab208) from R&D Systems. The blocking antibodies concentration used were 10 times higher than the one required to inhibit either the migration of monocytes induced by 20ng/ml rhMCP-1 or the migration of neutrophiles induced by 20ng/ml rhIL-8.
Human primary skin fibroblasts (HSF) were isolated by the explant procedure from normal human dermis and amplified in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% FCS (Cambrex). Cells were trypsinized 1:3 every week and used between passages 8 and 13. Human breast adenocarcinoma cell line HS578T, human fibrosarcoma cell line HT1080 and human melanoma cell line A2058 were amplified in Dulbecco's modified Eagle's medium supplemented with 8% FCS and trypsinized 1:10 every week. When indicated, cells were starved by serum deprivation for 16h. well-plates. In each experiment, a series of wells was dedicated to the evaluation of the silencing of the RhoGTPases by Western blotting analysis.
Immunoblotting and Zymography
Sub-confluent HSF were rinsed twice with and scraped in ice-cold PBS. One third of the cell suspension was used to measure the DNA content by a fluorimetric technique and the remaining was lysed in SDS-PAGE lysis buffer. Samples equivalent to 0.5µg DNA were separated on a 15% gel under reducing conditions. To analyse MMP-1 expression, serum free medium was conditioned by sub-confluent transfected fibroblasts at the indicated posttransfection time. Media conditioned by a number of fibroblasts equivalent to 0.5µg DNA were separated on a 10% gel under reducing conditions. Proteins were transferred to Immobilon-P PVDF membranes and immunodetected with the corresponding antibodies. The bands were visualised with the ECL system (Amrsham). To determine MMP-2 secretion, aliquots of conditioned media corresponding to 0.05 µg DNA were subjected to zymography analysis as previously described (Lambert et al., 2001b) .
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GTPase assays
The assay was carried out as previously described (Deroanne et al., 2003) . Briefly, cells were chilled on ice and lysed in ice-cold buffer containing 1% Triton X-100, 25 mM HEPES pH 7.3, 150 mM NaCl, 4% glycerol, 0.1 mM PMSF, 4 µg/ml aprotinin, 1 µg/ml leupeptin and 1µg/ml pepstatin. Lysates were centrifuged for 8 min. at 13000g. Supernatants were immediately frozen in liquid nitrogen and stored at -80° until used. An aliquot of each supernatant was denatured in SDS-PAGE lysis buffer before freezing to measure the total RhoGTPase content by Western blotting. For pull-down assays, supernatants were incubated for 30 min with 30 µg of GST-PBD protein containing the Cdc42 and Rac binding region of PAK-1B, or GST-RBD protein containing the Rho binding region of rhotekin affinity linked to glutathione-Sepharose beads (Ren et al., 1999; Sander et al., 1999) . The beads were washed 4 times in lysis buffer and boiled in 60µl SDS-PAGE lysis buffer.
RT-PCR analysis
The RT-PCR amplifications were performed in an automated thermocycler (GeneAmp PCR system 9600) using a GeneAmp Thermostable rTth Reverse Transcriptase RNA PCR kit, 
Rescue of Cdc42 knock-down
The entire coding sequence of Cdc42 was amplified by RT-PCR. The amplification product was mutated by mean of a PCR-based approach with mutated primers. Six silent mutations were introduced in the sequence targeted by the 1 st siCdc42 in order to make it resistant to this siRNA. The mutated Cdc42 cDNA (mCdc42) was cloned into pShuttle (CLONTECH Laboratories, Inc.). Sequencing confirmed that the 6 expected mutations were introduced into the cDNA. Rescue experiments were carried out with HS578T cells cultured in 6 well plates.
The cells were seeded at a density of 1.5x10 5 cells per well. Eight hours after seeding, they were transfected with 20nM of siScr or 20nM of siCdc42 for 14-16h following the protocol described above. Immediately after the washing step, 1µg of empty pShuttle or 1µg of pShuttle-mCdc42 was transfected into cells for 20-24h with 3µl of Genejuice tm (Novagen) following the manufacturer protocol. Each pool of transfected cells was trypsinized and seeded at sub-confluence in 6 well-plates. In each experiment, a series of wells was dedicated to the evaluation of the expression level of Cdc42 and MMP-1 by Western blotting analysis and another series to evaluate the expression level of both endogenous and mutated Cdc42 mRNA by RT-PCR.
RESULTS
Specific inhibition of RhoA, Rac1 and Cdc42 expression by siRNA.
The RhoA-targeting siRNA designed in a previous work (Deroanne et al., 2003) served as a guideline to define the siRNA target sequences for Rac1 and Cdc42 which were chosen in the same region of the mRNA sequence. As a control, an irrelevant siRNA (siScr), i.e. a randomly mixed sequence of the 1 st siRNA targeting Cdc42 was used. Human skin fibroblasts (HSF) were transiently transfected with either 20nM of the respective specific or control siRNA or treated with calcium phosphate alone. As shown in Figure 1A , Western blot analysis of whole cell lysates three days post-transfection revealed a more than 90% reduction in the RhoA and Cdc42 protein level and an 80% reduction in the Rac1 protein level without any significant modulation of the amount of ERK1,2 used as control. The irrelevant siRNA had no effect on any of these proteins. The specific inactivation of the RhoA, Rac1 and Cdc42 pathways was confirmed by pull-down assays which revealed a similar repression of their GTP-bound forms (not shown). Interestingly, the silencing of one RhoGTPase did not alter neither the expression level nor the activation level of the others. Repression of Cdc42 by more than 80% of the control was maintained for up to 7 days ( Fig.1B) , while Rac1 and RhoA were inhibited respectively for 5 and 9 days (not shown). As observed by phasecontrast microscopy, ablation of RhoA did not induce significant morphological alterations while that of Rac1 decreased lamellipodia formation and ablation of Cdc42 induced a more "dendritic" morphology ( Fig.2) .
The silencing of Cdc42 up-regulates the expression of MMP-1.
In HSF spread on a rigid support, the expression of MMP-1 is low as compared to experimental conditions where the actin cytoskeleton is disrupted by cytochalasin D (Lambert 11 et al., 1998, Unemori and Werb, 1986) or by culturing cells in a freely retracting collagen gel (Lambert et al., 1992; Langholz et al., 1995; Mauch et al., 1989) . In HSF cultured in monolayer the silencing of Cdc42 induced a 15 fold increased MMP-1 secretion, as measured by Western blot analysis of conditioned media. By contrast, the expression of MMP-1 was not affected by RhoA or Rac1 silencing ( Fig.3A and 3B ). The induction of MMP-1 was already detectable at a concentration of 2nM of siRNA and reached a maximum at 6nM and then leveled off up to 60nM of siRNA ( reported in other models (Sledz et al., 2003) . A second siRNA targeting another sequence of Cdc42 repressed Cdc42 as efficiently as the previous one and induced a similar overexpression of MMP-1 at both the mRNA and protein levels (Fig. 5) .
The MMP-1 overexpression induced by silencing Cdc42 requires Rac1
It has been reported in various models that a transient activation of either RhoA or Rac1 is a necessary step in the signal transduction cascade leading to MMP-1 production (Kheradmand et al., 1998; Werner et al., 2001 ). To address their role in the induction of MMP-1 following
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Cdc42 silencing, we performed a simultaneous repression of two or the three RhoGTPases by cotransfection of two or three siRNA. In these experiments, each RhoGTPase-targeting siRNA was used at a final concentration of 10 nM. The siScr was added to the transfection mix to reach a final concentration of 30 nM when only one or two specific siRNA were used.
Western blot analysis of whole cell lysates collected three days post-transfection confirmed the striking specificity of the repression of each RhoGTPase and revealed a lack of significant interference between the individual silencing after cotransfection with the siRNA targeting the other RhoGTPases ( suggesting that the RhoA-ROCK pathway is not involved in the process analysed here. It should be noted that Y27632 did not affect Cdc42 silencing (not shown).
The silencing of Cdc42 up-regulates IL-8 and MCP-1 expression.
To analyse the expression profile of cytokines by siCdc42 transfected HSF, proteoarrays were used to evaluate the concentration of 79 different cytokines in the conditioned media. They 
The induction of MMP-1 following Cdc42 silencing is mediated through the ERK1,2 pathway.
We noted that in starved HSF the electrophoretic pattern of ERK1,2 was modified following
Cdc42 silencing, suggesting a shift as observed when these proteins are phosphorylated. The analysis of the phosphorylation status of ERK1,2 and p38 with phospho-specific antibodies revealed that ablation of Cdc42 induced an activation of both ERK1,2 and p38 as compared to HSF transfected with other siRNAs (Fig. 8A ). The role of the ERK1,2, the p38 MAP kinase and PI3Kinase pathways in the intracellular signaling mediating the MMP-1 overexpression in Cdc42-ablated cells was evaluated by pharmacological inhibition. Transfected HSF were treated with U0126, a specific MEK1,2 inhibitor, and SB203580, a specific p38 MAP kinase inhibitor. The overexpression of MMP-1 following Cdc42 silencing was significantly decreased with a concentration of U0126 as low as 1µM. Similar results were observed in HSF transfected with the second siRNA targeting Cdc42 (Fig. 9) . On the contrary, inhibition of the p38 MAP kinase with SB203580 concentrations ranging from 2 to 6 µM significantly increased the MMP-1 expression (Fig. 8 ) while barely affecting it at concentrations ranging from 0.01 to 0.3 µM (Fig.9 ). These observations confirm the involvement of the ERK1,2 pathway in the overexpression of MMP-1 following ablation of Cdc42. The contribution of the PI3K and src signalling pathways was similarly investigated. The PI3K inhibitor LY294
did not affect MMP-1 expression in siCdc42 transfected HSF (Fig.8) . The tyrosine kinase inhibitor Herbimycin A, used at 260 nM, completely suppressed the induction of MMP-1,
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while a more specific src-kinase inhibitor PP2 (1 µM) was inactive (not shown). It should be noted that these inhibitors did not modify the silencing of Cdc42 (illustrated for U0126, SB203580 and LY294 in fig. 8 and 9 ).
The induction of MMP-1 following Cdc42 is observed in human cell lines from various origin.
To extend the significance of our results, the control of MMP-1 expression by Cdc42 was also (Fig.10) suggesting that this mechanism of regulation is not limited to HSF.
The rescue of Cdc42 silencing repressed MMP-1 overexpression
To confirm the role of Cdc42 in this control of MMP-1, the silencing of Cdc42 was rescued by expressing a Cdc42 mRNA made resistant to the siRNA by 6 silent mutations and coding for a wild-type Cdc42 protein (mCdc42). While each cell lines was easily transfected with the siRNA, preliminary analysis revealed that HS578T are by far the most efficiently transfected cells with an expression vector for the Enhanced Green Fluorescent Protein (not shown).
Rescue experiments were therefore carried out with this cell type. HS578T seeded in 6 well plates were first transfected overnight with 20nM of either siScr or siCdc42. Then, the cells were washed and immediately transfected with 1µg of empty pShuttle or 1µg of pShuttlemCdc42 for 20-24h. The specific measurement of the mCdc42 mRNA was achieved by RT-PCR using a primer complementary to a nucleotide sequence of pShuttle localised between the multiple cloning site and the polyadenylation site, i.e. in the 3'UTR specific of mCdc42 mRNA. The lack of amplification product when the RT step was omitted demonstrated that only mCdc42 mRNA was amplified (Fig. 11, top left panel) . RT-PCR analysis of total RNA extracted from HS578T 72h post-transfection demonstrated that (i) the silencing of the endogenous Cdc42 mRNA by the siCdc42 was as efficient after transfection of either the empty pShuttle or the pShuttle-mCdc42, (ii) the mutated Cdc42 mRNA was not ablated by the siCdc42 (Fig. 11) . Western blot analysis of whole cell lysates and of the conditioned medium of HS578T demonstrated that the reexpression of Cdc42 by transfecting pShuttle-mCdc42 after transfection of siCdc42 significantly decreased the expression of MMP-1 (Fig.11) . These results definitively confirm the specificity of the negative regulation operated by Cdc42 on MMP-1 expression. GTPase was observed. These results are in agreement with recent observations in Rac1-deficient macrophage (Wells et al., 2004) .
DISCUSSION
Recently, Sledz et al. (2003) reported the activation of the interferon system and observed a strong up-regulation of Stat1 upon siRNA transfection in T98G cells. In our system, this sideeffect did not occur since the Stat1 protein level was not increased upon transfection with 20nM of siRNAs. Moreover, the expression level of interferon-β was below the detection limit of the ELISA kit used here (not shown). These results suggest that the interferon system is not activated in HSF following siRNA transfection. This discrepancy could be related to the type of cell used and/or to the transfection method, calcium phosphate precipitation in our study versus "Oligofectamine In fibroblasts, it was reported that IL-1α and IL-1β are "signalling intermediates" acting through autocrine loops to mediate MMP-1 up-regulation triggered either by cytoskeleton disorganisation (West-Mays et al., 1995) , phagocytosis (Werner et al., 2001 ), integrin inactivation (Kheradmand et al., 1998) or interaction with specific ECM components (Utani et al., 2003) . However, these cytokines were undetectable at the protein level and barely Interestingly, Rac1 and Cdc42 were reported to control p38 MAP kinase activation (Minden et al., 1995) a process responsible for the inhibition of both ERK1,2 activation and MMP-1 expression (Singh et al., 1999; Westermarck et al., 2001) , while a specific inhibitor of the p38 MAP Kinase pathway is known to activate the ERK1,2 pathway (Aguirre-ghiso et al., 2003) .
Moreover, the inhibition of the Rac1 and Cdc42 pathways resulted in ERK1,2 activation (Zugasti et al., 2001) . The PI3Kinase and src-kinase pathways are also potentially involved in the regulation of MMPs in fibroblasts (Vincenti et al., 1996; Liao et al., 2003) . However, their specific inhibition did not affect MMP-1 expression in our model.
In fibroblasts, an antagonistic regulation of MMP-1 and type I collagen is usually observed by modulating cell-ECM interactions or integrin-mediated cytoskeleton organisation (Lambert et al., 1992; Lambert et al., 1998) . However, in three-dimensional collagen gel, the signalling 20 MMP-1 regulation by Cdc42 pathways modulating the expression of these genes are not coupled (Langholz et al., 1995) .
This is also the case in our model where the type I collagen expression was not regulated following Cdc42 silencing suggesting that Cdc42 do not exert a general control on the integrins-regulated genes.
In summary, our study is an additional evidence of the extreme power of the siRNA technology to analyse RhoGTPases functions. This approach enabled us to underscore the key Sample to sample variations in RT-PCR efficiency is controlled by a known copy number of synthetic RNA co-transcribed and co-amplified with the same primers which generate a product of larger size (*). 
